HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zn2+ Doped Ultrasmall Prussian Blue Nanotheranostic Agent for Breast Cancer Photothermal Therapy under MR Imaging Guidance.

Abstract
Prussian blue nanoprobes are widely studied and applied in tumor photothermal therapy (PTT) and magnetic resonance imaging (MRI), due to their low toxicity and excellent in vivo performance. However, the sizes of hitherto reported Prussian blue nanoprobes are generally larger than 50 nm, which greatly influence cell phagocytosis, in vivo circulation, and biodistribution. In this work, a novel method of doping zinc ions is used to control the size of Prussian blue nanoprobes. Consequently, the performances of the nanoprobes in PTT and MRI are both significantly improved. The results show that the minimum size of Prussian blue nanoprobes achieved by doping 10% zinc ions (abbreviated as SPBZn(10%)) is 3.8 ± 0.90 nm, and the maximum specific absorption coefficient, photothermal conversion efficiency, and longitudinal relaxation rates are 1.78 L g-1 cm-1 , 47.33%, and 18.40 mm-1 s-1 , respectively. In addition, the SPBZn(10%) nanoprobes provide excellent PTT efficacy on 4T1 tumor cells (killing rate: 90.3%) and breast cancer model (tumor inhibition rate: 69.4%). Toxicological experiment results show that the SPBZn(n%) nanoprobes exhibit no obvious in vitro cytotoxicity and they can be used safely in mice at doses below 100 mg kg-1 . Therefore, SPBZn(10%) nanoprobes can potentially be used for effective cancer theranostics.
AuthorsPingbo Shou, Zhangsen Yu, Yiting Wu, Qiang Feng, Bangyi Zhou, Jie Xing, Chuang Liu, Jinqing Tu, Ozioma Udochukwu Akakuru, Zhiqiu Ye, Xiaojuan Zhang, Zhenbo Lu, Luyun Zhang, Aiguo Wu
JournalAdvanced healthcare materials (Adv Healthc Mater) Vol. 9 Issue 1 Pg. e1900948 (01 2020) ISSN: 2192-2659 [Electronic] Germany
PMID31746549 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Ferrocyanides
  • Photosensitizing Agents
  • Zinc
  • ferric ferrocyanide
Topics
  • Animals
  • Breast Neoplasms (diagnostic imaging, therapy)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Female
  • Ferrocyanides (chemistry)
  • Humans
  • Hyperthermia, Induced
  • Infrared Rays
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Inbred BALB C
  • Nanostructures (chemistry)
  • Particle Size
  • Photosensitizing Agents (chemistry, metabolism, pharmacology, therapeutic use)
  • Photothermal Therapy (methods)
  • Theranostic Nanomedicine
  • Tissue Distribution
  • Xenograft Model Antitumor Assays
  • Zinc (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: